Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure

<div>Kaplan-Meier survival curves for device-related thrombus (DRT), TE events, bleeding and rehospitalization according to different anticoagulants: (a) the Kaplan-Meier survival curve of DRT, (b) systemic embolism (SE) events, and (c) bleeding events.</div>

Cardiovascular Therapeutics

fig2

Figure 2

Figure 2: Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure 

Figure 2 | Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure 